Navigating Complexity > Steering Decisions > Building Solutions

Brain-controlled hearing aids could cut through crowd noise

I've been bilaterally profoundly deaf since I was 18 months old (an unfortunate side effect of a severe bacterial meningitis infection I contracted as a child), and I've been through more hearing aids than I'd care to count.

What is your digital strategy? The Novartis /Sandoz approach

Digital strategy in healthcare as part of the wider digital health environment is coming more and more into focus at the large established biotech and pharma companies.

Big Pharma needs a new model for R&D for less wealthy markets

Kenan Malik wrote an opinion piece in the Guardian this week (Sunday 5th May) that summarized a key problem facing R&D in pharma; those most in need are likely those most unable to pay for drugs and vaccines.

Combination Failures & Futures—Much Ado About What?

For all the successes that the checkpoint inhibitors (CPIs) have had over the past 8 years since their first approvals, and all the industry noise around partnerships and newcos in Immuno-Oncology (IO), it can seem at times that more of the talk is around what is not working in IO.